Posts

Plastic Surgeon Uses Human Donated Placenta To Grow Hair

Plastic Surgeon Uses Human Donated Placenta To Grow Hair

/in /by

Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair

For men and women in the United States, hair loss is an increasing concern. Thinning hair, male pattern baldness, and ageing all contribute to losing hair. Many think that the only effective treatment for hair loss is hair transplant surgery.

However, Dr Javad Sajan, a plastic surgeon at PRP In Seattle uses a unique blend of platelet-rich plasma, donated placental growth factors, and stem cells derived from pig bladders to provide a unique non-surgical hair restoration treatment.

During the procedure, platelet-rich plasma, or PRP, is created from the patient’s own blood. It is then combined with the placental growth factors and pig bladder stem cells. This proprietary recipe is then injected into the scalp and hair follicles to promote regeneration of the follicles, skin, and hair. Patients normally require four to six sessions, but the results can be similar to those seen from surgical hair transplant methods.

Dr Sajan discusses the impact placental growth factors have had on his hair restoration practice, “Placental growth factors have revolutionized hair restoration. Before this, hair transplant surgery was my most common strategy for hair restoration. Now, placental growth factors are my number one hair restoration procedure.”

Dr Sajan at PRP In Seattle offers stem cell hair restoration treatments for $5,000 for a package of six treatments.

You can find more information about PRP In Seattle and Dr. Sajan on their website: https://www.prpinseattle.com/.

You can also view before and after photos of the procedure: https://www.prpinseattle.com/before-after-gallery/?type_0=album&album_gallery_id_0=2

About PRP In Seattle:

PRP In Seattle (https://www.prpinseattle.com/) is the leader for PRP hair restoration, cosmetic injections, and skincare in the Seattle area.

The non-surgical techniques utilized at PRP In Seattle have revolutionized the way platelet-rich plasma is used in the plastic surgery field.

Employing master estheticians, physicians assistants, qualified nurse injectors, and two MDs, PRP In Seattle offers the most modern and skilled techniques for stem cell hair restoration and other PRP therapies.

Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair

Source

Previous Posts

Plastic Surgeon Uses Human Donated Placenta To Grow Hair

Plastic Surgeon Uses Human Donated Placenta To Grow Hair

/in /by

Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair

For men and women in the United States, hair loss is an increasing concern. Thinning hair, male pattern baldness, and ageing all contribute to losing hair. Many think that the only effective treatment for hair loss is hair transplant surgery.

However, Dr Javad Sajan, a plastic surgeon at PRP In Seattle uses a unique blend of platelet-rich plasma, donated placental growth factors, and stem cells derived from pig bladders to provide a unique non-surgical hair restoration treatment.

During the procedure, platelet-rich plasma, or PRP, is created from the patient’s own blood. It is then combined with the placental growth factors and pig bladder stem cells. This proprietary recipe is then injected into the scalp and hair follicles to promote regeneration of the follicles, skin, and hair. Patients normally require four to six sessions, but the results can be similar to those seen from surgical hair transplant methods.

Dr Sajan discusses the impact placental growth factors have had on his hair restoration practice, “Placental growth factors have revolutionized hair restoration. Before this, hair transplant surgery was my most common strategy for hair restoration. Now, placental growth factors are my number one hair restoration procedure.”

Dr Sajan at PRP In Seattle offers stem cell hair restoration treatments for $5,000 for a package of six treatments.

You can find more information about PRP In Seattle and Dr. Sajan on their website: https://www.prpinseattle.com/.

You can also view before and after photos of the procedure: https://www.prpinseattle.com/before-after-gallery/?type_0=album&album_gallery_id_0=2

About PRP In Seattle:

PRP In Seattle (https://www.prpinseattle.com/) is the leader for PRP hair restoration, cosmetic injections, and skincare in the Seattle area.

The non-surgical techniques utilized at PRP In Seattle have revolutionized the way platelet-rich plasma is used in the plastic surgery field.

Employing master estheticians, physicians assistants, qualified nurse injectors, and two MDs, PRP In Seattle offers the most modern and skilled techniques for stem cell hair restoration and other PRP therapies.

Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair

Source

Previous Posts

PRP Workshop To Enhance Hair Restoration

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market

/in /by

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market

The global platelet-rich plasma & stem cell alopecia treatment market is expected to reach a value of approximately US$ 450.5 Mn by the end of 2026, expanding at a high single-digit CAGR during the forecast period. Factors such as an increase in demand for accurate and prompt treatment of alopecia and advancements in platelet-rich plasma and stem cell therapies that have revolutionized the diagnostic science are likely to boost the market.

Moreover, a rise in awareness about platelet-rich plasma therapies and stem cell therapies is expected to drive the global market during the forecast period. Increased awareness has driven demand for platelet-rich plasma therapy & stem cell therapy in the past few years in countries such as Japan, India, Brazil, and Russia and developed regions such as North America and Europe. Additionally, private players are actively promoting the advantages of treatment of alopecia with stem cell therapy across the globe.

A rise in the incidence rates of autoimmune hair loss disorders such as alopecia is estimated to boost the platelet-rich plasma & stem cell alopecia treatment market. According to the Journal of Clinical, Cosmetic, and Investigational Dermatology, 2015, the lifetime incidence rate of alopecia areata is approximately 2% worldwide.

This is expected to propel the market. However, a lack of treatment approval and high cost of alopecia treatment are likely to hinder the growth of platelet-rich plasma & stem cell alopecia treatment market.
platelet-rich plasma stem cell alopecia treatment market

The global platelet-rich plasma & stem cell alopecia treatment market has been segmented based on treatment, indication, end-user, and region. In terms of treatment, the global market has been classified into platelet-rich plasma therapies and stem cell therapy. The platelet-rich plasma therapies segment held a major market share and is expected to expand at a significant CAGR, owing to the effectiveness of the therapies in the treatment of many types of alopecia.

Platelet-rich plasma therapies have revolutionized alopecia treatment by reducing costs, treatment duration, and recovery time for patients. The stem cell therapy segment has been further divided into bone marrow and adipose.

Based on indication, the global platelet-rich plasma & stem cell alopecia treatment market has been divided into androgenic alopecia, congenital alopecia, cicatricial or scarring alopecia, and others. The androgenic alopecia segment holds a key market share as androgenic alopecia is the most common cause of hair loss in both men and women.

About 45% of men and 35% of women develop androgenic alopecia by 60, which is the highest among all the types of alopecia. A study published in the International Journal of Women’s Dermatology in 2019 revealed that the use of PRP to treat androgenic alopecia is promising due to its autologous nature, minimal invasiveness, lack of major side effects, and low cost compared to hair restoration surgery.

In terms of end-user, the global market has been categorized into hospitals, dermatology clinics, and others. The dermatology clinics segment held a major share of the market, followed by the hospital segment, in 2017. This is due to an increase in preference among patients for dermatology clinics where they can avail combined treatment for hair, skin, and nails.

Moreover, an increase in the incidence of alopecia, a rise in access to dermatologists, and a surge in awareness about services provided by dermatology clinics are factors attributable to the high market share of the segment. Certain hospitals have diagnostic facilities, including hair & scalp computerized analysis, in-house laboratory, and a number of different treatment options. This is likely to boost the global market, especially in developing regions.

In terms of region, the global platelet-rich plasma & stem cell alopecia treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global platelet-rich plasma & stem cell alopecia treatment market, owing to a high rate of adoption of advanced products and rise in market penetration of new market entrants with novel technology in the region.

Moreover, a high prevalence of alopecia in the region is imposing a significant economic burden and is boosting demand for affordable care.

This, in turn, is driving demand for platelet-rich plasma & stem cell alopecia treatment. According to the National Institute of Health in 2015, 95% of women suffer from androgenetic alopecia in the U.S. This has led the country to dominate the platelet-rich plasma & stem cell alopecia treatment market in North America. The U.S. is anticipated to maintain its leading position in the market in the region during the forecast period.

Additionally, the increased application of PRP for the treatment of alopecia has been observed in the past few years. This is likely to fuel the market in the region. The market in the Asia Pacific is projected to expand at a significantly high CAGR during the forecast period, owing to the emergence of strong local manufacturers offering various technological advancements for platelet-rich plasma & stem cell alopecia treatment at lower prices and increase in awareness among people about these treatment methods.

Furthermore, an increase in health care expenditure and investments by key players in emerging regions such as China and India are estimated to fuel the market in the region.

Major players operating in the global platelet-rich plasma & stem cell alopecia treatment market include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy. Key players are focused on research & development of alopecia treatment by investing in platelet-rich plasma & stem cell alopecia therapies.

Mergers & acquisitions, collaborations, and partnerships are helping companies expand their footprint and further develop effective treatments for alopecia.

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market

Source

Previous Posts

PRP Workshop To Enhance Hair Restoration

Platelet Rich Plasma And Stem Cell Alopecia Treatment Market

/in /by

Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Expects to See Significant Growth

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market by Indication (Cicatricial or Scarring Alopecia, Androgenic Alopecia, Congenital Alopecia, Others) Treatment (Stem Cell Therapy, Platelet Rich Plasma Therapies) End User (Dermatology Clinics, Hospitals, Others) – Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

Stem cell and platelet rich plasma (PRP) treatments are considered as regenerative or bio drugs. They are insignificantly invasive and subsequently diminish the requirement for medical procedure.

These treatments help animate, remake, and reinforce hair regrowth, rather than expelling harmed tissue from the scalp. Expanding inclination for insignificantly obtrusive strategies over medical procedures is anticipated to support the U.S. market.

Drivers and Restraints

Novel treatments for alopecia are favored by dermatologists and patients over regular medications, for example, corticosteroids. More prominent inclination for these treatments emerges from proficient and quicker hair regrowth when contrasted with other corticosteroid medications. Furthermore, simplicity of organization of these novel treatments is anticipated to drive request over the figure time frame.

Regional Insights

The United States market comprises of an expansive number of suppliers offering novel alopecia treatment alternatives, for example, PRP and stem cell treatments.

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Russia
Italy
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
South America
Brazil
Argentina
Columbia
Rest of South America
Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Competitive Analysis                        

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Regen Lab SA
Eclipse
Stemcell Technologies, Inc.
Kerastem
Glofinn Oy
Histogen, Inc.
RepliCel Life Sciences

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Platelet Rich Plasma And Stem Cell Alopecia Treatment Market Expects to See Significant Growth

Source

Previous Posts

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market

/in /by

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market – Global Industry Analysis & Outlook : Will Worth US$ 450 Mn by 2026

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Overview

This report analyzes the current and future scenario of the global platelet rich plasma & stem cell alopecia treatment market for the period 2018 to 2026. Rise in awareness about platelet rich plasma therapies and stem cell therapies, increase in funding for alopecia treatment research and stem cell research, and increase in the incidence of autoimmune hair loss disorders are likely to be major drivers of the global platelet rich plasma & stem cell alopecia treatment market during the forecast period.

The global platelet rich plasma & stem cell alopecia treatment market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on treatment, indication, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market.

The section also provides presence of key players working in the development of stem cell and platelet rich pharmaceutical products, thereby presenting a thorough analysis of the overall competitive scenario in the global platelet rich plasma & stem cell alopecia treatment market.

Global Platelet Rich Plasma and stem Cell Alopecia Treatment Market: Key Segments

Based on treatment, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into platelet rich plasma therapy and stem cell therapy. The stem cell therapy segment has been further classified into bone marrow treatment and adipose treatment. In terms of indication, the global platelet rich plasma & stem cell alopecia treatment market has been classified into androgenic alopecia, congenital alopecia, cicatricial or scarring alopecia and others. Based on end-user, the global platelet rich plasma & stem cell alopecia treatment market has been divided into hospitals, dermatology clinics, and others. The market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market: Regional Outlook

In terms of region, the global platelet rich plasma & stem cell alopecia treatment market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report

The report also profiles major players operating in the global platelet rich plasma & stem cell alopecia treatment market based on various attributes, such as company overview, financial overview, pipeline portfolio, product portfolio, business strategies, and recent developments. The players covered in the report include Kerastem, Eclipse, Regen Lab SA, Stemcell Technologies, Inc., RepliCel Life Sciences, Histogen, Inc., and Glofinn Oy.

The global platelet rich plasma & stem cell alopecia treatment market has been segmented as below:

– Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by Treatment
– Platelet Rich Plasma Therapies
– Stem Cell Therapy
– Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by Indication
– Androgenic Alopecia
– Congenital Alopecia
– Cicatricial or Scarring Alopecia
– Others
– Global Platelet Rich Plasma & Stem Cell Alopecia Treatment Market, by End-user
– Hospitals
– Dermatology Clinics
– Others

Global Platelet Rich Plasma & Stem Cell Alopecia Treatment , by Region- North America
– U.S.
– Canada
– Europe
– U.K.
– Germany
– France
– Italy
– Spain
– Rest of Europe
– Asia Pacific
– India
– China
– Japan
– Australia & New Zealand
– Rest of Asia Pacific
– Latin America
– Brazil
– Mexico
– Rest of Latin America
– Middle East & Africa
– South Africa
– GCC Countries
– Rest of Middle East & Africa

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market

 

Source

Previous Posts

PRP Injections: The Holy Grail for Hair Regrowth Gets a Makeover for 2019

PRP Injections The Holy Grail for Hair Regrowth Gets a Makeover for 2019

/in /by

PRP Injections: The Holy Grail for Hair Regrowth Gets a Makeover for 2019

Reflections: the Center for Cosmetic Medicine is well-known as one of the nation’s most prestigious cosmetics-only medical practice. With a team of cosmetic physicians focused on providing cutting-edge, science-backed treatments that create the very best results possible, hair restoration has become one of the treatments patients request most often from our team. What we’ve found is that hair transplant surgery, even FUE transplant, isn’t the golden solution most people have been sold.

Hair Transplants Solve the Problem As It Is Now, but the Results Won’t Last If You Don’t Solve the Underlying Cause of Hair Loss.

Hair loss is a complex problem, requiring complex solutions.

When hair loss is not complete, we tend to recommend patients aggressively pursue both options to increase hair diameter and the growth of new hairs, and to also address the underlying causes of that hair loss, to prevent its progression. What good is it to grow new hair if you continue to lose more of the old ones? If you effectively manage the underlying causes of the hair loss by encouraging the growth of new hairs, then you’ve got real, transformative results that are going to last.

When hair loss is complete or severe enough to create areas of less than 30% hair coverage remaining, transplant procedures are often sold as the perfect solution. What we now know is that transplanting hair into an area of scalp that is predisposed to killing off its hair follicles, will negatively affect those transplanted hairs, as well as what remains of the native follicles. If you, instead, transplant the hair and fight the hormones and imbalances that are causing hair loss, this not only protects the remaining and transplanted hair, but can positively affect the diameter, or thickness, of the individual hairs as well.

What Combination of Treatments is Ideal for Hair Restoration & Regrowth in the Long-Term?

As stated before, hair loss is a complex problem with many potential contributing factors that vary by the individual. These are some of the types of treatments we mix together for our patients:

Nutritional supplements that ensure the right nutrition is present to grow healthy hair
Hormonal modifiers to correct imbalances that lead to hair loss
Antifungal treatments (fungal infections and some diseases well-treated by the same products can cause temporary hair loss)
Regenerative aesthetics procedures, including Platelet-Rich Plasma(PRP) and Nanofat
Reparative cascade triggering with Lasers and Microneedling

Regardless of their starting point in the hair loss process, we find the best, most cost-effective, and enduring results happen for patients who are willing to be aggressive at the outset of treatment and to continue to maintain their results over the long-haul with supplements, medications, and occasional maintenance treatments.

Quality Matters: Not all PRP is Created Equal

As patients seek treatments for hair loss, we encourage them to discuss with their providers not just the adjuncts that will help support the PRP as it helps to stimulate new hair growth, but to also discuss the strength or concentration levels of the platelets. Some systems concentrate platelets at 2-3x the levels seen in normal blood, others at 8 or more times more concentrated.

More Information on Hair Regrowth
For more information on hair regrowth treatments, please visit: https://www.reflectionscenter.com/new-jersey-medical-spa/hair-growth-treatments/

PRP Injections: The Holy Grail for Hair Regrowth Gets a Makeover for 2019

Source

 

Previous Posts

Global Platelet Rich Plasma Industry

Global Platelet Rich Plasma Industry

/in /by

Global Platelet Rich Plasma Industry Market Research 2019

In this report, we analyze the Platelet Rich Plasma industry from two aspects. One part is about its production and the other part is about its consumption.

In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019.

We also make a prediction of its production and consumption in coming 2019-2024.

At the same time, we classify different Platelet Rich Plasma based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Platelet Rich Plasma industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Key players in the global Platelet Rich Plasma market include:

AdiStem Ltd.
Arthrex, Inc.
Biomet, Inc.
Cesca Therapeutics, Inc.
DePuy Synthes, Inc.
EmCyte Corporation
Exactech, Inc.
Harvest Technologies Corp.
Nuo Therapeutics, Inc.
Regen Lab SA
Stryker Corporation
Market segmentation, by product types:
Pure PRP
Leukocyte-Rich PRP
Leukocyte-Rich Fibrin

Market segmentation, by applications:

Orthopedics
Cosmetic Surgery and Dermatology
Ophthalmic Surgery
Neurosurgery
General surgery
Others

Market segmentation, by regions:

North America
Europe
Asia Pacific
The Middle East and Africa
Latin America

The report can answer the following questions:

1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Platelet Rich Plasma?
2. Who are the global key manufacturers of Platelet Rich Plasma industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Platelet Rich Plasma? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Platelet Rich Plasma? What is the manufacturing process of Platelet Rich Plasma?
5. The economic impact on Platelet Rich Plasma industry and development trend of Platelet Rich Plasma industry.
6. What will the Platelet Rich Plasma market size and the growth rate be in 2024?
7. What are the key factors driving the global Platelet Rich Plasma industry?
8. What are the key market trends impacting the growth of the Platelet Rich Plasma market?
9. What are the Platelet Rich Plasma market challenges to market growth?
10. What are the Platelet Rich Plasma market opportunities and threats faced by the vendors in the global Platelet Rich Plasma market?

Objective of Studies:

1. To provide a detailed analysis of the market structure along with the forecast of the various segments and sub-segments of the global Platelet Rich Plasma market.
2. To provide insights about factors affecting the market growth. To analyze the Platelet Rich Plasma market based on various factors- price analysis, supply chain analysis, Porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, Latin America and Rest of the World.
4. To provide country-level analysis of the market with respect to the current market size and future prospective.
5. To provide country-level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Platelet Rich Plasma market.S

Global Platelet Rich Plasma Industry Market Research 2019

 

Source

 

 

Previous Posts